D-0798-2022 Class II Terminated

Recalled by Olympia Compounding Pharmacy dba Olympia Pharmacy — Orlando, FL

Recall Details

Product Type
Drugs
Report Date
May 4, 2022
Initiation Date
April 4, 2022
Termination Date
June 17, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1871 vials

Product Description

QM-2 Papaverine 30 mg/mL. Phentolamine 3 mg/mL . Alprostadil 60 mcg/mL . Atropine 0.2 mg/mL, Multi-Dose 10 mL vial, Rx Only Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC: 73198-0018-10.

Reason for Recall

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Lots: D41219 BUD: 4/19/2022, I24C13 BUD: 9/13/2022